The 2025 GOP budget law includes significant cuts to healthcare programs that are expected to result in higher premiums and changes to Medicaid eligibility rules. An estimated 2 million children could lose health insurance coverage as a result of these cuts. The changes are creating uncertainty around Medicaid coverage determinations and affordability challenges for families. The law represents a major shift in federal healthcare policy affecting both Medicaid and marketplace coverage.
Why it mattersMedicaid managed care organizations will face enrollment declines, changes to member mix, and operational adjustments as eligibility rules tighten and children lose coverage under the new federal budget law.
Managed Care · CHIP · Finance
The CDC confirmed 2,030 measles cases in the U.S. as of June 4, 2026, with 1,890 cases (93%) linked to outbreaks. This total is rapidly approaching the full-year 2025 count. Measles is a highly contagious vaccine-preventable disease that poses particular risks to immunocompromised populations and young children. For Medicaid managed care plans, rising case counts may trigger increased EPSDT screening requirements, higher utilization of pediatric acute care and emergency services, and potential quality measure impacts related to childhood immunization rates.
Why it mattersMedicaid MCOs serving pediatric and immunocompromised populations may see increased acute care utilization and face pressure to improve immunization rates under HEDIS and quality bonus programs.
Managed Care · Maternal · CHIP
The Trump administration has reclassified thousands of HHS employees who shape policy to Schedule F status, stripping civil service protections and making them easier to terminate. The change affects staff across HHS agencies including CMS who develop regulations, guidance, and policy implementation. This action mirrors a similar executive order from Trump's first term that was rescinded by the Biden administration. The reclassification takes effect immediately and could lead to significant turnover among career staff who oversee Medicaid policy development and managed care oversight.
Why it mattersPotential turnover among CMS career staff who write managed care rules, issue guidance, and oversee MCO compliance could create regulatory uncertainty and disrupt existing agency relationships that health plans rely on for policy interpretation.
Managed Care
The Food and Drug Administration has initiated a safety review of mifepristone, the abortion medication, according to an administration official. The retrospective analysis could lead to restrictions on the drug's use and distribution channels. Anti-abortion groups view this as a significant development that may result in tighter federal controls over medication abortion access. The timing and scope of the review have not been disclosed.
Why it mattersIf FDA restricts mifepristone distribution or availability, Medicaid managed care plans may face changes to pharmacy networks, prior authorization protocols, and access to medication abortion services covered under state Medicaid programs.
Maternal · Pharmacy · Managed Care